# Extracellular Vesicles as Biological Templates for Next-Generation Drug-Coated Cardiovascular Devices: Cellular Mechanisms of Vascular Healing, Inflammation, and Restenosis

## TL;DR

This paper explores how extracellular vesicles can inspire new drug-coated cardiovascular devices that promote healing while preventing restenosis.

## Contribution

The paper introduces a framework for EV-inspired device engineering that integrates biological signaling for coordinated vascular healing.

## Key findings

- EV-inspired coatings can coordinate endothelial healing, smooth muscle responses, and inflammation resolution.
- EV-based strategies can reduce the trade-off between restenosis prevention and delayed vascular healing.

## Abstract

What are the main findings?
Extracellular vesicle (EV) biology offers a mechanistic roadmap for redesigning drug-coated cardiovascular devices beyond non-selective antiproliferative drug delivery.EV-inspired coating strategies can integrate pathway-information-based cargo signaling and surface interactions to coordinate endothelial healing, smooth muscle responses, and inflammation resolution.

Extracellular vesicle (EV) biology offers a mechanistic roadmap for redesigning drug-coated cardiovascular devices beyond non-selective antiproliferative drug delivery.

EV-inspired coating strategies can integrate pathway-information-based cargo signaling and surface interactions to coordinate endothelial healing, smooth muscle responses, and inflammation resolution.

What is the implication of the main findings?
EV-inspired devices can reduce the trade-off between restenosis prevention and delayed vascular healing by delivering cell-directed drug delivery that promotes healing at the injury site.Implementation will require standardized EV characterization, scalable manufacturing/quality control, and clinically relevant endpoints that capture both efficacy and quality of healing.

EV-inspired devices can reduce the trade-off between restenosis prevention and delayed vascular healing by delivering cell-directed drug delivery that promotes healing at the injury site.

Implementation will require standardized EV characterization, scalable manufacturing/quality control, and clinically relevant endpoints that capture both efficacy and quality of healing.

While drug-eluting cardiovascular devices, including drug-eluting stents and drug-coated balloons, have significantly reduced restenosis rates, they remain limited by delayed vascular healing, chronic inflammation, and late adverse events. These limitations reflect a fundamental mismatch between current device pharmacology, which relies on nonselective antiproliferative drugs, and the highly coordinated, cell-specific programs that orchestrate vascular repair. Extracellular vesicles (EVs), nanometer-scale membrane-bound particles secreted by virtually all cell types, provide a biologically evolved platform for intercellular communication and cargo delivery. In the cardiovascular system, EVs regulate endothelial regeneration, smooth muscle cell phenotype, extracellular matrix remodeling, and macrophage polarization through precisely orchestrated combinations of miRNA, proteins, and lipids. Here, we synthesize mechanistic insights into EV biogenesis, cargo selection, recruitment, and functional effects in vascular healing and inflammation and translate these into a formal framework for EV-inspired device engineering. We discuss how EV-based or EV-mimetic coatings can be designed to sense the local microenvironment, deliver encoded biological “instruction sets,” and function within ECM-mimetic scaffolds to couple local stent healing with systemic tissue repair. Finally, we outline the manufacturing, regulatory, and clinical trial issues that must be addressed for EV-inspired cardiovascular devices to transition from proof of concept to clinical reality. By shifting the focus from pharmacological suppression to biological regulation of healing, EV-based strategies offer a path to resolve the long-standing tradeoff between restenosis prevention and durable vascular healing.